CPI at LIPOSOME RESEARCH DAYS 2024 - Accelerating LNP Formulation Development & Manufacture
Wed, 26 Jun 2024
Event Details
Download our presentation
Predicting how a drug delivery mechanism will perform is one of the biggest challenges for innovators in RNA-based vaccines and therapeutics. In this presentation, Dr Juliana Haggerty shares valuable insight into new approaches to LNP formulation, manufacture, and characterisation.
About The Intracellular Drug Delivery Centre
Dr Juliana Haggerty’s presentation provides the most recent research updates from the UK’s Intracellular Drug Delivery Centre (IDDC). The case studies covered include:
- Advanced high throughput screening and characterisation
- The use of adaptive DoE to enhance our understanding of structure-function relationships
- Intensified and continuous LNP manufacturing approaches
Now open to industry, the IDDC explores how the chemistry and formulation of drug delivery systems affect both physicochemical characteristics and biological performance. It provides vital knowledge to accelerate the development of new approaches that boost the efficiency and specificity of drug delivery.
The IDDC is a collaboration between University of Strathclyde Glasgow, Imperial College London, the University of Liverpool and The Medicines Discovery Catapult.
Speaker
Dr Juliana Haggerty
Head of Intracellular Drug Delivery Centre, CPI
Juliana currently heads up our Intracellular Drug Delivery Centre, a CPI led UK initiative bringing together Catapult Centres and Universities into a distributed Centre of Excellence. This centre will accelerate the advancement of RNA-based therapies by driving innovation in the design, manufacture and characterisation of advanced drug delivery technologies. These technologies have the potential to create a revolution in medicine by enabling the delivery of genetic medicines and nucleic acid therapies and vaccines, as seen through the success of the LNP-enabled COVID-19 vaccines.